Experience of psychiatric management of schizophrenia with fluphenazine decanoate
Grosser, H.H.
Diseases of the Nervous System 31(Suppl): 32-36
1970
ISSN/ISBN: 0012-3714 PMID: 4920312 Document Number: 22267
Document emailed within 1 workday
Related Documents
Náhunek, K.; Rodová, A.; Svestka, J. 1970: Clinical experience with fluphenazine decanoate in psychoses Activitas Nervosa Superior 12(1): 47-49Small, J.G.; Kellams, J. 1974: Early hospital experience with fluphenazine decanoate Diseases of the Nervous System 35(10): 453-456
Chandra, O.; Bernard, J.; Matussek, N. 1974: Long-term trial of fluphenazine decanoate and flupenthixol decanoate for cataleptic activity and effect on motor activity in rats Arzneimittel-Forschung 24(11): 1821-1824
Stevens, B. 1976: The social value of fluphenazine decanoate Acta Psychiatrica Belgica 76(5): 792-804
Timm, U.; Pfeifer, S. 1973: Assay and determination of fluphenazine decanoate in oily solution Die Pharmazie 28(11): 793
Drtil, J. 1989: Treatment of patients dependent on tobacco with fluphenazine decanoate Activitas Nervosa Superior 31(2): 116-117
Adamson, L.; Curry, S.H.; Bridges, P.K.; Firestone, A.F.; Lavin, N.I.; Lewis, D.M.; Watson, R.D.; Xavier, C.M.; Anderson, J.A. 1973: Fluphenazine decanoate trial in chronic in-patient schizophrenics failing to absorb oral chlorpromazine Diseases of the Nervous System 34(4): 181-191
Zbytovský, J. 1993: Haloperidol decanoate (Janssen) in the treatment of schizophrenia Ceskoslovenska Psychiatrie 89(1): 27-29
Kenway, A.K.; Masheter, H.C. 1971: Pimozide compared with fluphenazine in schizophrenia British Journal of Clinical Practice 25(2): 69-72
Proselkova, M.E.; Uzhanov, N.V. 1991: Experience with using etaperazine (perphenazine) in the treatment of patients with schizophrenia in a preschool psychiatric department Zhurnal Nevropatologii i Psikhiatrii Imeni S.S. Korsakova 91(1): 120-122
Niturad, A.; Ciurezu, T.; Cucu, I. 1974: Maintenance treatment of schizophrenia with long-acting fluphenazine Activitas Nervosa Superior 16(3): 167
Schooler, N.R.; Levine, J.; Severe, J.B. 1979: Depot fluphenazine in the prevention of relapse in schizophrenia: evaluation of a treatment regimen Psychopharmacology Bulletin 15(2): 44-47
Pempkowiak, L.; Januszkiewicz-Grabiasowa, A.; Góra, S. 1979: Blood serum concentration of long-acting fluphenazine in patients with various forms of schizophrenia Psychiatria Polska 13(1): 1-8
Eufe, R.; Wegener, G. 1979: Double-blind comparison of 2 depot neuroleptics (perphenazine enanthate and flupentixol decanoate) in chronic schizophrenia Der Nervenarzt 50(8): 534-539
Brosteanu, E.R.; Floru, L. 1977: The behaviour of visually evoked potentials (VEP) in schizophrenia under gradually rising doses of fluphenazine dihydrochloride Arzneimittel-Forschung 27(6): 1231-1233
Levenson, A.J.; Burnett, G.B.; Nottingham, J.D.; Sermas, C.E.; Thornby, J.I. 1976: Speed and rate of remission in acute schizophrenia: a comparison of intramuscularly administered fluphenazine HC1 with thiothixene and haloperidol Current Therapeutic Research 20(5): 695-700
Zbytovský, J.; Zapletálek, M. 1989: Longitudinal study of the effect, tolerance and undesired side effects of injection haloperidol decanoate applied in different psychiatric indications Activitas Nervosa Superior 31(4): 266-267
Dencker, S.J.; Elgen, K. 1980: Aspects of clinical psychiatric research on depot neuroleptics. The presentation of two double-blind trials with cis(z)-clopenthixol decanoate and a withdrawal study in schizophrenics Acta Psychiatrica Scandinavica. Supplementum 279: 5-9
Król, K.; Krystof, J. 1974: Personal experience with prolonged-action fluphenazine Psychiatria Polska 8(2): 149-155
Sedivec, V.; Bornová, L.; Chaloupková, L.; Dvoráková, M. 1986: Initial experience in working at the psychiatric intensive care unit at the Psychiatric Clinic in Plzen Ceskoslovenska Psychiatrie 82(6): 374-377